The Challenge
A top-20 pharmaceutical company was drowning in clinical trial data. Their data science team — understaffed and spread across 8 active trials — took an average of 14 weeks to process and analyze each trial phase’s data. Promising drug candidates were being delayed by data bottlenecks, not science.
Our Approach
We deployed a dedicated AI Squad (AI Agents + FDE + Support × 2) embedded directly within their R&D data team:
AI-Powered Data Ingestion: Built intelligent agents to automatically normalize, validate, and reconcile clinical data from 200+ trial sites with different data formats and reporting standards.
Automated Signal Detection: Deployed ML models trained on the company’s historical trial data to flag safety signals and efficacy patterns weeks earlier than manual review.
Intelligent Reporting: Created an automated reporting pipeline that generated regulatory-ready data summaries, cutting report preparation from 3 weeks to 2 days.
The Results
- 75% reduction in data processing time: From 14 weeks to under 4 weeks per trial phase.
- 3x more drug candidates evaluated: The freed-up capacity allowed the team to run parallel analyses they previously couldn’t resource.
- $200M in accelerated pipeline value: Getting viable candidates to the next phase faster translated directly to patent-protected market time.
- Zero regulatory findings: All AI-generated reports passed FDA audit without corrections.